期刊文献+

107例直肠癌Cox-2,p53及PCNA表达分析 被引量:2

An Analysis of Expression of Cox-2,p53 and PCNA in 107 Cases with Rectal Carcinoma
下载PDF
导出
摘要 [目的]探讨环氧化酶2(Cox-2),p53及增殖细胞核抗原(PCNA)在直肠癌中表达的意义。[方法]对107例存档直肠癌标本,分别采用Cox-2,p53及PCNA三种单克隆抗体进行免疫组化染色(SP法)。[结果]Cox-2,p53及PCNA阳性表达率在肿瘤有淋巴结转移(阳性表达率分别为80.9%、68.3%、84.1%)直肠癌病例中分别显著高于肿瘤无淋巴结转移(52.2%、47.7%、40.9%),在Dukes’C期患者阳性表达率分别显著高于Dukes’A、B期(P<0.05)。[结论]直肠癌Cox-2,p53及PCNA表达与淋巴结转移和疾病进展等相关。 [Purpose ] To investigate the expression of Cox-2, p53 and PCNA in rectal carcinoma. [Methods ] Expression of Cox-2, p53 and PCNA were detected with monoclonal antibodies by immunohistochemical SP staining in 107 cases with reetal carcinoma. [Results] The positive rates of Cox-2, p53 and PCNA in cases with lymphnode metastasis (80.9%,68.3%,84.1%) were significantly higher than those without lymphnode metastasis (52.2%,47.7%,40.9%) respectively and the positve rates in Dukes' stage C cases were significantly higher than those in Dukes'stage A and B(P〈0.05). [Conclusion] The expression of Cox-2, p53 and PCNA is closed related to lvmnhnode metastasis and state of illness in rectal eareinoma.
机构地区 浙江省台州医院
出处 《中国肿瘤》 CAS 2006年第4期278-279,共2页 China Cancer
关键词 直肠肿瘤 环氧化酶2 P53 增殖细胞核抗原 预后 rectal neoplasms Cox-2, p53 PCNA, prognosis
  • 相关文献

参考文献8

  • 1姬社青,花亚伟,马杰,徐勇超,韩少良.结直肠癌COX-2、p53、PCNA和ki-67表达[J].中国肿瘤,2004,13(8):527-529. 被引量:8
  • 2陈志康,欧阳植庭.癌胚抗原和环氧化酶2的表达与结直肠癌的关系[J].癌症,2003,22(2):164-167. 被引量:17
  • 3Hla T, Bishop-Bailey D, Liu CH , et al . Cyclooxygenase-1and-2 isoenzymes[J]. Int J Biochem Cell Biol, 1999, 31:551-557.
  • 4Bissonnette M, Khare S, Von Lintig FC, et al. Mutational and nonmutational activation of p21 ras in rat colonic azoxymethane-in-duced tumors :effects on mitogen activated protein kinase, yclooxy-genase-2, and cyclin D1[J]. Cancer Res,2000,60:4602-4609.
  • 5来茂德.中国结直肠癌发生发展相关基因[J].世界华人消化杂志,2001,9(11):1227-1232. 被引量:11
  • 6Heikh RA, Min BH, Yasmeen S, et al. Correlation of Ki-67, p53 and Adnab-9 immunohistochmical staining and ploidy with clinical and histopathologic features of severely dysplastic colorectal adenomas[J]. Dis Sci, 2003,48(1):223-229.
  • 7Wa J, Mao Y, He L, et al. A new cell proliferating marker:cytosonic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma[J].Anticancer Res, 2000,20(6C):4815-4820.
  • 8Tsujii M,Raymond N. Alterations in cellular adhesion and apoptosis in epitheial cells overexpressing prostagland in endoperoxide synthase [J]. Cell, 1995, 83 (3): 493-501.

二级参考文献75

共引文献31

同被引文献24

  • 1吴卉娟,刘少扬,江大琼,曾俊,龚玲玲.宫颈癌中COX-2与p53、E-cadherin蛋白表达的关系[J].临床与实验病理学杂志,2004,20(5):568-571. 被引量:19
  • 2安莉,王静,俞森洋.COX-2和p53蛋白在非小细胞肺癌中的表达及与微血管生成的相关性研究[J].中国肿瘤临床与康复,2007,14(1):1-4. 被引量:10
  • 3陈玉芳,万美珍,史永娟.食管癌中Cox-2与p53表达及相关意义[J].现代肿瘤医学,2007,15(3):360-362. 被引量:4
  • 4汪建平.结、直肠与肛管疾病[A].见:吴在德主编.外科学[M].第6版.北京:人民卫生出版社,2003:511.
  • 5GERDES J,LEMKE H, BAISCH H,et al. Cell cyde analysis of a cell proliferation associated human nuclear antigen defined by the monoelonal antibody Ki67[J]. Immunol, 1994,133(1):710 - 716.
  • 6URRUTICOECHEA A, SMITH I E, DOWSETT M, et al. Proliferation marker Ki - 67 in early breast cancer[J]. Clin Oncol,2005,23(28):7212 - 7220.
  • 7AZAMBUJA E,CARDOSO F,GASTRO G J R, et al. Ki - 67 as prognostic marker in early breast cancer: a meta - analysis of published studies involving 12 155 patients[J]. Br J cancer, 2007,96(10) : 1504 - 1513.
  • 8BUCHYNSKA L G,NESINA I P,YRUCHENLO N P,et al.Expression of p63,p21WAF1/CIP1,p16INK4A and Ki-67 proteins in serous ovarian tumors[J].Exp Oncol,2007, 29(1):49 - 53.
  • 9SAHIN A A,RO J Y, BROWN R W,et al. Assessment of Ki - 67 derived tumor proliferative activity in colorectal adenocarcinomas[J]. Mod Pathol, 1994,7 : 17 - 22.
  • 10KUNIYASU H, OVE N, SHIQEISHI, et al. Prospective study of Ki - 67 labeling index in the mucosa adjacent to cancer as a marker for colorectal cancer metastasis [J]. Exp Clin Cancer Rest 2001 , 20(4) : 543 - 548.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部